Deutsche Bank Aktiengesellschaft »

Apellis Pharmaceuticals shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $51M 857k 59.86
2023-09-30 $12M 324k 38.04
2023-06-30 $44M 478k 91.10
2023-03-31 $40M 599k 65.96
2022-12-31 $14M 263k 51.71
2022-09-30 $39M 568k 68.30
2022-06-30 $31M 695k 45.23
2022-03-31 $28M 544k 50.81
2021-12-31 $16M 339k 47.28
2021-09-30 $9.6M 291k 32.96
2021-06-30 $20M 320k 63.20
2021-03-31 $18M 420k 42.91
2020-12-31 $36M 634k 57.20
2020-09-30 $17M 557k 30.17
2020-06-30 $18M 545k 32.66
2020-03-31 $5.0M 185k 26.80
2019-12-31 $5.0M 165k 30.51
2019-09-30 $3.1M 131k 24.02
2019-06-30 $2.8M 114k 24.44
2019-03-31 $2.5M 128k 19.29
2018-12-31 $342k 26k 13.12
2018-09-30 $1.3M 73k 17.70
2018-06-30 $1.3M 58k 21.98
2018-03-31 $259k 12k 21.81
2017-12-31 $516k 24k 21.68